Stevanato Group Spa (STVN) has released an update.
Stevanato Group S.p.A., a prominent provider of pharmaceutical solutions, has announced a public offering of $300 million in ordinary shares, with half offered by the company and half by its major shareholder, Stevanato Holding S.r.l. The company plans to use the proceeds for general corporate purposes, which includes ongoing investment activities and working capital needs. The offering, managed by Morgan Stanley and William Blair, will also give underwriters a 30-day option to purchase up to 15% additional shares.
For further insights into STVN stock, check out TipRanks’ Stock Analysis page.
